2696.HK
Shanghai Henlius Biotech, Inc.
HKSEHKDEQUITY
Healthcare
DELAYED
Last price
68.60
▼ 1.75 (2.49%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
70.35
Prev close
70.35
Day high
71.55
Day low
67.60
Volume
409.85K
Market cap
$37.40B
P/E (TTM)
37.28
52W range
50.25 – 92.00
Day trading desk
Gap from prior close
+0.00%
Prior close 70.35
VWAP
68.64
-0.06% from price
Relative volume
0.97×
Normal
Session range
5.84%
67.60 – 71.55
Position in range
25%
Near session low
ATR (14D)
3.29
4.79% of price
Prior day high
71.30
PDH
Prior day low
67.00
PDL
Bid / ask spread
—
Quote not published
Session volume
854.95K
Avg 883.40K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.93%
+3.3%
1M
+19.10%
+15.4%
3M
-2.21%
-5.3%
6M
-4.66%
-15.7%
YTD
+20.56%
+8.3%
1Y
-8.23%
-28.2%
3Y
+435.94%
+361.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 2696.HK open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
401.83M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 7, 26 | Zhu (Jun) Chief Executive Officer |
SELL | 91.44K | $766.35K | Direct |
| Jun 27, 26 | Zhu (Jun) Chief Executive Officer |
— | 375.00K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Zhu (Jun) |
Chief Executive Officer | 333.56K | Sale |
Fundamentals
Market cap$37.40B
Enterprise value$40.51B
Revenue (TTM)$7.44B
Gross profit$5.55B
EBITDA$1.22B
Net income$867.35M
EPS (TTM)$1.84
Free cash flow—
Total cash$818.38M
Total debt$3.95B
Book value / share$9.72
Shares outstanding347.78M
Float137.53M
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E37.28
Forward P/E37.50
PEG ratio—
Price / sales—
Price / book7.06
EV / revenue5.45
EV / EBITDA33.32
Gross margin74.69%
Operating margin14.04%
Profit margin11.67%
Return on equity21.83%
Return on assets4.47%
Debt / equity87.01
Current ratio0.78
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $6.67B | $5.72B | $5.39B | $3.21B | +16.5% |
| Operating revenue | $6.67B | $5.72B | $5.39B | $3.21B | +16.5% |
| Cost of revenue | $1.68B | $1.54B | $1.48B | $844.62M | +9.2% |
| Gross profit | $4.98B | $4.18B | $3.92B | $2.37B | +19.1% |
| Research & development | $1.52B | $1.04B | $1.12B | $1.39B | +46.4% |
| Selling, general & admin | $2.64B | $2.29B | $2.14B | $1.40B | +15.4% |
| Total operating expense | $4.06B | $3.25B | $3.20B | $2.73B | +25.0% |
| Operating income | $927.56M | $939.13M | $721.80M | -$358.69M | -1.2% |
| Net interest income | -$83.71M | -$101.18M | -$102.39M | -$102.10M | +17.3% |
| Pre-tax income | $811.72M | $845.88M | $569.58M | -$693.89M | -4.0% |
| Tax provision | -$15.32M | $25.41M | $23.56M | $1.37M | -160.3% |
| Net income | $827.04M | $820.47M | $546.02M | -$695.26M | +0.8% |
| Net income to common | $827.04M | $820.47M | $546.02M | -$695.26M | +0.8% |
| Basic EPS | 1.52 | 1.51 | 1.01 | -1.28 | +0.7% |
| Diluted EPS | 1.51 | 1.51 | 1.00 | -1.28 | 0.0% |
| EBIT | $914.22M | $968.77M | $680.12M | -$588.22M | -5.6% |
| EBITDA | $1.34B | $1.34B | $1.04B | -$310.61M | +0.0% |
| Basic shares | 543.49M | 543.49M | 543.30M | 542.02M | 0.0% |
| Diluted shares | 545.93M | 543.49M | 543.37M | 542.02M | +0.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $772.21M | $772.96M | $987.66M | $680.48M | -0.1% |
| Cash & short-term investments | $772.21M | $772.96M | $987.66M | $680.48M | -0.1% |
| Accounts receivable | $1.82B | $857.43M | $647.83M | $455.51M | +111.8% |
| Inventory | $612.41M | $728.27M | $757.36M | $757.31M | -15.9% |
| Total current assets | $3.49B | $2.51B | $2.68B | $2.19B | +38.8% |
| Property, plant & equipment | $2.58B | $2.70B | $2.65B | $2.23B | -4.4% |
| Goodwill & intangibles | $6.16B | $5.36B | $4.51B | $4.33B | +15.1% |
| Total assets | $12.36B | $10.60B | $9.90B | $8.92B | +16.6% |
| Total current liabilities | $4.94B | $5.03B | $5.07B | $5.00B | -1.8% |
| Current debt | $2.19B | $2.49B | $2.71B | $2.44B | -12.3% |
| Long-term debt | $1.25B | $951.27M | $1.11B | $975.29M | +31.3% |
| Total debt | $3.60B | $3.65B | $4.09B | $3.68B | -1.4% |
| Total liabilities | $8.40B | $7.58B | $7.71B | $7.29B | +10.8% |
| Retained earnings | -$2.28B | -$3.10B | -$3.92B | -$4.47B | +26.6% |
| Shareholder equity | $3.96B | $3.01B | $2.19B | $1.64B | +31.4% |
| Working capital | -$1.45B | -$2.52B | -$2.39B | -$2.81B | +42.3% |
| Net tangible assets | -$2.20B | -$2.34B | -$2.32B | -$2.70B | +6.0% |
| Shares issued | 543.49M | 543.49M | 543.49M | 543.49M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $811.72M | $845.88M | $569.58M | -$693.89M | -4.0% |
| Depreciation & amortisation | $429.41M | $374.80M | $359.23M | $277.60M | +14.6% |
| Stock-based compensation | $124.52M | $0 | $2.59M | $12.52M | — |
| Change in working capital | -$167.11M | -$56.63M | -$21.11M | $1.10B | -195.1% |
| Operating cash flow | $1.31B | $1.24B | $1.05B | $981.62M | +5.1% |
| Capital expenditure | -$1.20B | -$837.21M | -$1.01B | -$1.37B | -43.3% |
| Investing cash flow | -$1.20B | -$909.97M | -$1.00B | -$1.36B | -31.5% |
| Financing cash flow | -$93.86M | -$643.37M | $144.43M | $858.02M | +85.4% |
| Free cash flow | $105.88M | $404.68M | $36.48M | -$383.67M | -73.8% |
| End cash position | $579.21M | $571.40M | $867.66M | $673.48M | +1.4% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $772.21M | $889.16M | $772.96M | -13.2% |
| Cash & short-term investments | $772.21M | $889.16M | $772.96M | -13.2% |
| Accounts receivable | $1.82B | $1.18B | $857.43M | +53.3% |
| Inventory | $612.41M | $838.12M | $728.27M | -26.9% |
| Total current assets | $3.49B | $3.22B | $2.51B | +8.2% |
| Property, plant & equipment | $2.58B | $2.63B | $2.70B | -1.9% |
| Goodwill & intangibles | $6.16B | $5.67B | $5.36B | +8.7% |
| Total assets | $12.36B | $11.55B | $10.60B | +7.0% |
| Total current liabilities | $4.94B | $4.72B | $5.03B | +4.6% |
| Current debt | $2.19B | $2.51B | $2.49B | -12.7% |
| Long-term debt | $1.25B | $959.62M | $951.27M | +30.1% |
| Total debt | $3.60B | $3.67B | $3.65B | -2.0% |
| Total liabilities | $8.40B | $8.14B | $7.58B | +3.2% |
| Retained earnings | -$2.28B | -$2.71B | -$3.10B | +16.1% |
| Shareholder equity | $3.96B | $3.41B | $3.01B | +16.2% |
| Working capital | -$1.45B | -$1.50B | -$2.52B | +3.2% |
| Net tangible assets | -$2.20B | -$2.26B | -$2.34B | +2.6% |
| Shares issued | 543.49M | 543.49M | 543.49M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | 2.28 | 7 | $7.73B | +16.0% |
| Next year | 1.57 | 7 | $7.63B | -1.3% |
Analyst targets & ownership
Mean target$104.16
High target$119.85
Low target$91.58
Implied upside51.84%
Analyst count6
ConsensusSTRONG BUY
Strong buy / Buy1 / 6
Hold0
Sell / Strong sell0 / 0
Held by insiders73.75%
Held by institutions17.23%
Institutions holding46
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
68.36
+0.35% from price
SMA 20
63.36
+8.28% from price
SMA 50
62.27
+10.17% from price
SMA 100
67.35
+1.85% from price
SMA 200
66.05
+3.86% from price
EMA 12
66.78
+2.73% from price
EMA 26
64.57
+6.25% from price
EMA 50
64.00
+7.18% from price
RSI (14)
57.8
Neutral
MACD (12,26,9)
2.21
Hist 0.52
ATR (14)
3.29
4.79% of price
Realised vol 30D
68.0%
Annualised
Bollinger upper
75.55
20, 2σ
Bollinger lower
51.16
20, 2σ
50 / 200 cross
Death
62.27 vs 66.05
Trend bias
Above 200
+3.86%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.11
Less volatile than market
Correlation to SPY
-0.02
Largely independent
Realised vol 30D
68.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-42.1%
Peak to trough
Max drawdown 5Y
-71.3%
Peak to trough
ATR 14
3.29
4.79% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Kane voted German footballer of the year
AFP · 11m ago
Asphalt Expert Robert Stewart Explains Asphalt Driveway Installation Preparation in HelloNation
PR Newswire · 14m ago
Is GE Vernova Under $1,000 a Bargain or a Trap? Here's the Honest Answer.
Motley Fool · 15m ago
The Idiot’s Guide to Stocks
24/7 Wall St. · 17m ago
Exclusive: Anthropic's $2 Trillion Valuation Faces a Reality Check—SPCX Offers a Warning, Wall Street Veteran Says
Benzinga Private Markets · 17m ago
Trump made a multimillion-dollar bond bet — and Fed Chair Kevin Warsh could shape the outcome. What investors can learn
Moneywise · 18m ago
DREAMO and DREAMOSIS Bring the Collectible Character Into a New Physical-Digital World
PR Newswire · 18m ago
Bio Ionic Partners with Ulta Beauty on Limited Edition Jade Dream Collection
PR Newswire · 18m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.